chemiluminescentmicroparticleimmunoassay(CMIA)usedforthequalitative detectionofantibodytohepatitisBcoreantigen(anti-HBc)inhumanserumand plasmaspecimensontheAlinitysSystem.TheAlinitysAnti-HBcassayisintendedto screenindividualhumandonors,includingvolunteerdonorsofwholebloodandblood ...
In this study, the neutralizing effect of the anti-SARS-CoV-2 S1 protein IgG, which was detected using the chemiluminescence microparticle immunoassay (CMIA)-based SARS-CoV-2 IgG II Quant (Abbott, Waukegan, IL, USA) test in SARS-CoV-2 infected and/or vaccinated individuals, was investigated...